R. Ramon, C Welffens-Ekra 1 (principal investigator) Microbiology: D Bonard 1 , P Combe 1 , M Dosso 1 , L Gautier-Charpentier 2 Sylla-Koko 1 , Y Traore 2 , P Van de Perre 2 Molecular biology: AM Cassel-Beraud 2 Abidjan health facilities: Anonkoua-Koute, Ouassakara, Yopougon and Yopougon-Attie, Dioulasso health facilities: Accart-Ville Centre Hospitalier National Souro Sanou. 1 Abidjan Centre, 2 Bobo-Dioulasso Centre, 3 Bordeaux Coordination Unit, 4 Paris. REFERENCES 1 Mofenson LM, Mc Intyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission, pp.2237-2281, 2000.

S. Wiktor, V. Leroy, and E. Ekpini, 24-Month efficacy of short-course maternal zidovudine for the prevention of mother-to-child HIV-1 transmission in a breast feeding population:a pooled analysis of two randomized clinical trials in West Africa. XIII International AIDS Conference, pp.9-14, 2000.

F. Dabis, V. Leroy, and K. Castetbon, Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000, AIDS, vol.14, issue.8, pp.1017-1041, 2000.
DOI : 10.1097/00002030-200005260-00014

P. De-perre and M. N. , Interventions to reduce mother to child transmission of HIV-1, AIDS, vol.9, pp.59-66, 1995.

A. Duliège, C. Amos, and S. Felton, Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins, The Journal of Pediatrics, vol.126, issue.4, pp.625-657, 1995.
DOI : 10.1016/S0022-3476(95)70365-9

R. Chuachoowong, N. Shaffer, and W. Siriwasin, Short???Course Antenatal Zidovudine Reduces Both Cervicovaginal Human Immunodeficiency Virus Type 1 RNA Levels and Risk of Perinatal Transmission, The Journal of Infectious Diseases, vol.181, issue.1, pp.99-106, 2000.
DOI : 10.1086/315179

L. Mandelbrot, M. Burgard, and J. Teglas, Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers, AIDS, vol.13, issue.15, pp.2143-2152, 1999.
DOI : 10.1097/00002030-199910220-00018

P. Gaillard, C. Verhofstede, and F. Mwanyumba, Exposure to HIV-1 during delivery and mother-to-child transmission, AIDS, vol.14, issue.15, pp.2341-2349, 2000.
DOI : 10.1097/00002030-200010200-00015

W. Graham and M. Newell, Seizing the opportunity: collaborative initiatives to reduce HIV and maternal mortality, The Lancet, vol.353, issue.9155, pp.836-845, 1999.
DOI : 10.1016/S0140-6736(98)12374-7

L. Burman, P. Christensen, and K. Christensen, Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour, The Lancet, vol.340, issue.8811, pp.65-74, 1992.
DOI : 10.1016/0140-6736(92)90393-H

R. Biggar, P. Miotti, and T. Taha, Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission, The Lancet, vol.347, issue.9016, pp.1647-50, 1996.
DOI : 10.1016/S0140-6736(96)91486-5

E. Taha, R. Biggar, and R. Broadhead, Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in malawi: clinical trial, BMJ, vol.315, issue.7102, pp.216-225, 1997.
DOI : 10.1136/bmj.315.7102.216

P. Gaillard, F. Mwanyumba, and C. Verhofstede, Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya, AIDS, vol.15, issue.3, pp.389-96, 2001.
DOI : 10.1097/00002030-200102160-00012

S. Sattar and V. Springthorpe, Survival and Disinfectant Inactivation of the Human Immunodeficiency Virus: A Critical Review, Clinical Infectious Diseases, vol.13, issue.3, pp.430-477, 1991.
DOI : 10.1093/clinids/13.3.430

M. Wainberg, B. Spira, and G. Bleau, Inactivation of Human Immunodeficiency Virus Type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride, J Clin Microbiol, vol.28, pp.156-164, 1990.

R. Erny and C. Sibody, Les tampons au chlorure de benzalkonium:tolérance locale et effet sur la glaire cervicale, J Gynécol Obstét Biol Reprod, vol.12, pp.767-74, 1983.

P. Msellati, N. Meda, and V. Leroy, Safety and acceptability of vaginal disinfection with benzalkonium chloride in HIV infected pregnant women in west Africa: ANRS 049b phase II randomized, double blinded placebo controlled trial. DITRAME Study Group, Sexually Transmitted Infections, vol.75, issue.6, pp.420-425, 1999.
DOI : 10.1136/sti.75.6.420

F. Dabis, P. Msellati, and N. Méda, 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in C??te d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial, The Lancet, vol.353, issue.9155, pp.786-92, 1999.
DOI : 10.1016/S0140-6736(98)11046-2

P. Msellati, N. Meda, and C. Welffens-ekra, Zidovudine and reduction of HIV vertical transmission in Africa, Am J Public Health, vol.89, pp.946-953, 1999.

F. Dabis, P. Msellati, and M. Newell, Methodology of interventions trials to reduce mother to child transmission of HIV with special reference to developing countries, AIDS, vol.9, pp.67-74, 1995.

F. Dabis, P. Msellati, and D. Dunn, Estimating the rate of mother-to-child transmission of HIV, AIDS, vol.7, pp.17-201139, 1992.
URL : https://hal.archives-ouvertes.fr/inserm-00263481

R. Nduati, G. John, and D. Mbori-ngacha, Effect of Breastfeeding and Formula Feeding on Transmission of HIV-1: A Randomized Clinical Trial, Obstetrical & Gynecological Survey, vol.55, issue.8, pp.1167-74, 2000.
DOI : 10.1097/00006254-200008000-00010

R. Spira, P. Lepage, and P. Msellati, Natural History of Human Immunodefiency Virus Type 1&nbspInfection in Children: A Five-Year Prospective Study in Rwanda, PEDIATRICS, vol.104, issue.5, p.56, 1999.
DOI : 10.1542/peds.104.5.e56

F. Dabis, N. Elenga, and N. Meda, 18-Month mortality and perinatal exposure to zidovudine in West Africa, AIDS, vol.15, issue.6, pp.771-780, 2001.
DOI : 10.1097/00002030-200104130-00013